"TESTEA yakazvimiririra yakagadzira zvigadzirwa zveCCIDID-19 diagnostic test kits yakaramba ichiwedzera musika uye mari yayo yekutengesa yakapfuura bhiriyoni 1.2 yuan ($ 178 miriyoni) mukota yekutanga yegore rino, inova gore negore kuwedzera kwe600%. ” Panguva yekubvunzurudzwa kwake nemushambadziri weHangzhou Yuhang, director weTestsea Zhou Bin anodaro.
Kubva pakatanga COVID-19, Testsea yakagadzira 2019-nCoV test kits, uye yakatevera iyo R & D yeakawanda akasiyana diagnostic reagents emutant strains, ayo akatengeswa kunyika dzinopfuura zana nematunhu kuburikidza nevashambadzi vekunze uye kutenga hurumende. .
"Mukupindura denda rakawedzera, Testsea yakawedzera nzvimbo yekugadzira, yakawedzera michina nevashandi. Testsea yakashandisawo zvizere hunyanzvi hwayo uye mabhenefiti, akateedzera mutemo wemhando yepamusoro budiriro. Nekuwedzera kwehuwandu hwekugadzira, takawana kukura nekukurumidza mukuita kwebhizinesi kubvira 2020. " Akadaro Zhou Bin.
Nemoyo wekutenda, tichashanda nesimba uye kutungamirira Testsea kuedza kukunda marudzi ese ematambudziko uye kugadzirisa marudzi ese ematambudziko, kuitira kuti titakure mutoro mukuru wemagariro evanhu uye kuramba tichibatsira mukudzivirira nekudzora denda repasi rose uye kuita zvizere. gadziriro dzenguva yepost-COVID-19.
Zvichakadaro, kudiwa kwezvigadzirwa zvedu zvekukurumidza kuongororwa zviri kukwira, chinangwa chedu chegore rose chinotarisirwa kuwana 2.0 bhiriyoni yuan ($ 300 miriyoni) panosvika 2022.
Bhizinesi redu rakave rakakura uye rakakura, nekuwedzera uye kwakamisikidzwa kwehutongi hwemukati, matarenda akawanda anotungamira uye matarenda ehunyanzvi, kambani yakatora danho rakasimba mukurongeka kwepasirese.
Testsea inogara yakazvipira kugadzira mhinduro dzakasimba uye dzinoshanda mukuziva utachiona, kuongorora zvirwere uye kuchengetedza hutano.
Nguva yekutumira: May-19-2022